Fine Chemicals: A Promising Outlook

The outlook for contract manufacturers looks promising despite cost pressures and increased competition, pharmaceutical ingredient manufacturers say. Active pharma ingredient (API) and pharma intermediate producers plan further expansion of their activities, including investments in new geographies. Regulatory bodies, meanwhile, are tightening their scrutiny of the sector. Hardy: Plans to establish a manufacturing presence in Asia and U.S. in 2012. The $40-billion/year global API market is expected to grow 4%-5%/year in volume terms and 0%-1%/year in value terms...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers